Baseline characteristics and patient reported outcome data of patients prescribed etanercept: web-based and telephone evaluation

BACKGROUND: The anti-TNF inhibitor, etanercept is administered as a once or twice weekly subcutaneous injection for the treatment of rheumatoid arthritis, psoriasis, ankylosing spondylitis, psoriatic arthritis and juvenile idiopathic arthritis (JIA). Limited data from the patients' perspective...

Descripción completa

Detalles Bibliográficos
Autores principales: Wade, Alan G, Crawford, Gordon M, Pumford, Neil, Koscielny, Volker, Maycock, Susan, McConnachie, Alex
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3141801/
https://www.ncbi.nlm.nih.gov/pubmed/21672203
http://dx.doi.org/10.1186/1471-2288-11-91

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3141801/
https://www.ncbi.nlm.nih.gov/pubmed/21672203
http://dx.doi.org/10.1186/1471-2288-11-91

Ejemplares similares